Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ramin Fathi

Dermatology Scottsdale, AZ Medical Doctor

NPI 1215374186 CMS profile 2782820

13400 E Shea Blvd, Scottsdale, AZ 85259

Open in the dashboard

General payments

$3,218

123 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ramin Fathi of Scottsdale, AZ is reported in the CMS Open Payments database as having received $3,218 across 123 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 55th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $696 29
2024 General $870 38
2023 General $483 18
2022 General $388 18
2021 General $70 4
2020 General $129 6
2019 General $582 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ramin Fathi
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Ramin Fathi were reported at $696. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Ramin Fathi Dermatology median Middle half National median
2019 $582 $454 $129–$1,240 $163
2020 $129 $235 $81–$756 $114
2021 $70 $377 $108–$1,108 $132
2022 $388 $514 $143–$1,391 $149
2023 $483 $607 $159–$1,674 $160
2024 $870 $751 $204–$1,903 $164
2025 $696 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $527 24 payments
  2. Sun Pharmaceutical Industries Inc. $257 12 payments
  3. E.R. Squibb & Sons, L.L.C. $246 8 payments
  4. Genzyme Corporation $229 8 payments
  5. Janssen Biotech, Inc. $192 9 payments
  6. Regeneron Healthcare Solutions, Inc. $161 7 payments
  7. Stryker Corporation $156 1 payment
  8. Allergan Inc. $145 3 payments
  9. Solta Medical, a division of Bausch Health US, LLC $131 1 payment
  10. STRATA Skin Sciences, Inc. $127 4 payments
  11. Other $1,046 46 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,211 122 payments
  2. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. SKYRIZI $403 17 payments
  2. DUPIXENT Immunology $295 10 payments
  3. TREMFYA $192 9 payments
  4. Odomzo $167 7 payments
  5. ENTELLUS - XPRESS ENT DILATION SYSTEM $156 1 payment
  6. BLU-U $150 6 payments
  7. SOTYKTU $146 7 payments
  8. DUPIXENT Inflammation And Immunology $144 6 payments
  9. VTAMA $141 8 payments
  10. XTRAC $127 4 payments
  11. Other $1,402 62 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

787

Median for Dermatology: 534

Drug cost

$118,323

Median for Dermatology: $67,151

Branded share of claims

7.6%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 24 $99,376
Tacrolimus Generic 22 $4,692
Clobetasol Propionate Generic 96 $3,505
Fluorouracil Generic 41 $2,879
Triamcinolone Acetonide Generic 132 $1,796
Ketoconazole Generic 134 $1,776
Gentamicin Sulfate Generic 24 $951
Minoxidil Generic 56 $731
Imiquimod Generic 23 $712
Doxycycline Hyclate Generic 54 $545

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 131 billing codes

Paid by Medicare

$693,960

Of which drugs: $32,845

Medicare patients

946

Average age 75

Services billed

8,566

450 women, 496 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 62%
Arthritis 42%
Ischemic heart disease 23%
Chronic kidney disease 18%
Cancer 18%
Osteoporosis 17%
Diabetes 16%
Depression 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) J7308 Office 67 106 $32,788
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 23 52 $39

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 14 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
  • AbbVie, Inc. $133
$133 — —
VTAMA
  • Dermavant Sciences, Inc. $112
$112 — —
DUPIXENT
  • GENZYME CORPORATION $82
  • Regeneron Healthcare Solutions, Inc. $22
$104 24 —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $79
$79 — —
Zoryve
  • Arcutis Biotherapeutics, Inc. $36
$36 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 14 in the dashboard with a free account

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record